HOME>Corporate Social Responsibility>Disclosure of Payments to Healthcare Professionals
Innovation today, healthier tomorrows

Disclosure of payments to Healthcare Professionals

We are committed to the highest standards of conduct in all of our operations, including how we partner with physicians and medical institutions.

We believe in working transparently with the healthcare professionals that help us to develop innovative treatments that improve people's health and wellbeing. In Europe we have many years of experience in collaborating with healthcare professionals on both early scientific research and within clinical trial programmes.

We believe in fair reimbursement to healthcare professionals for their time and expertise and are committed to ensuring the transparency of our relationships with health professionals.  Across Europe the pharmaceutical industry has announced its intention to disclose payments to health professionals at an individual level by 2016 for payments made in 2015 onwards. Together with other ABPI member companies we are taking steps towards disclosing the total figure paid to healthcare professionals, plus the number of healthcare professionals who received payments. 

Download 31st December 2014 report

Download 31st March 2014 report

Download 31st December 2012 report

Home | Contact Us | Site Map | Terms of Use | Privacy and Cookie Notice | About Sumitomo Dainippon Pharma
SUNOVION is a registered trademark of Sumitomo Dainippon Pharma Co., Ltd., Osaka, Japan. © 2018 Sunovion Pharmaceuticals Europe Ltd., All rights reserved.